visikol.com Open in urlscan Pro
162.144.117.79  Public Scan

Form analysis
1 forms found in the DOM

GET https://visikol.com/

<form role="search" class="searchform fusion-search-form  fusion-search-form-classic" method="get" action="https://visikol.com/">
  <div class="fusion-search-form-content">
    <div class="fusion-search-field search-field"> <label><span class="screen-reader-text">Search for:</span> <input type="search" value="" name="s" class="s" placeholder="Search..." required="" aria-required="true" aria-label="Search..."> </label>
    </div>
    <div class="fusion-search-button search-button"> <input type="submit" class="fusion-search-submit searchsubmit" aria-label="Search" value=""></div>
  </div>
</form>

Text Content

Skip to content
MENUMENU
 * Home
 * Contract Research Services
   * * * In Vitro and 3D Cell Culture Assay Services
         * High Content Screening
         * Antibody Penetration and Pharmacokinetics
         * Apoptosis Assay
         * ATP Content
         * Blood Brain Barrier Permeability
         * Cell Painting Assay
         * Cell Proliferation
         * Fibrosis and Collagen Deposition
         * Cancer
           * Apoptosis Assay
           * Antiproliferative Assay
           * Cytotoxicity Assay
           * Immune Cell Infiltration
         * Toxicity and Safety Assessment
           * Hepatotoxicity
           * Mitochondrial Function Assay
           * Cholestasis Assay
           * Steatosis and Phospholipidosis
           * Cell Viability and Cytotoxicity
           * Neurotoxicity
         * Scratch/Wound Healing Assay
         * Custom Assay Development
     * * Cleared Tissue 3D Imaging and Analysis Services
         * Immunolabeling
         * 3D Imaging of Thick Specimens
         * Confocal Microscopy Service
         * 3D Image Analysis
         * Blood Vessel Segmentation and Analysis
         * Examples of Customer Projects
       * Histology and Digital Pathology
         * Highly-Multiplexed Immunohistochemistry Services
           * Technology Overview
           * Validated Antibodies
           * Multiplex Panels
           * Spatial Profiling of RNA with HCR
         * Imaging Mass Cytometry Service
         * Histological Tissue Processing
         * Slide Scanning
     * * Precision-Cut Liver Slice Assays
         * Study Formats
         * Endpoints
       * Image and Slide Analysis
         * Biomarker Quantification and Colocalization
         * Blood Vessel Segmentation and Analysis
         * Cell Counting
         * Classification with Machine Learning
         * Immune Cell Population Analysis for Immuno-oncology
         * Tumor Area Quantification
       * Request a Quote
       * Contact Us
   * * 
 * Therapeutic Areas
   * Oncology
   * NAFLD, NASH, and Liver Disease
   * Toxicity Assessment and Screening
   * Inflammation and Fibrosis
   * Ophthalmology
 * HUREL® Micro Livers
   * HUREL® Products
   * HUREL® Resources
   * HUREL® Services
 * Products
   * Purchase
   * Request a Sample
   * Contact Us
   * Visikol HISTO Tissue Clearing
     * Overview
     * Protocol
     * Validated Kits
     * Buffer Recipes
     * Validated Antibodies
     * Product Information
     * Whole Tissue Imaging Guidance
     * Reversible Tissue Clearing
     * Publications
     * MSDS/CoA
   * Visikol HISTO-M for 3D Cell Models
     * Overview
     * Protocol
     * Neuronal Organoid Validated Kits
     * Buffer Recipes
     * Product Information
     * 3D Cell Culture Imaging Guidance
     * Publications
     * MSDS/CoA
   * Visikol for Plant Biology
     * Protocol
     * Comparison to Traditional Plant Tissue Clearing
     * Education Focused
     * Simplified Quality Control
     * White Paper: Adulteration
     * Publications
     * Visikol MOUNT
     * MSDS/CoA
   * HUREL Products
 * Resources
   * Blog
   * Application Notes
   * Posters
   * Tutorials
   * Videos
   * Events
 * About
   * About
   * Careers
   * Distributors
   * Map and Directions
   * Terms of Service
 * Contact Us
 * Search for:
   





Get Started Today
Visikol – Contract Research Services – HomeMike Johnson2022-08-10T10:10:00-05:00


SPOTLIGHT



BLOOD BRAIN BARRIER PERMEABILITY ASSAY






Utilizing a novel BBB in vitro model, we offer an in vitro assay capable of
assessing the penetration kinetics of molecules passing across the BBB.



Read More


HUREL PRIMARY HEPATOCYTE MICRO LIVERS






The HUREL portfolio of primary hepatocyte models and services are now part of
Visikol which includes over ten animal species and multiple new services.

Read More


CELL PAINTING
ASSAY






Cell painting is a high-content, multiplexed image-based assay that is utilized
for cytological profiling where several compartments of the cell are “painted”
with a variety of organelle specific stains. 

Read More


HIGHLY MULTIPLEXED SLIDE IMAGING






We provide our Clients with the ability to move beyond traditional slide
labeling and imaging such that they can achieve 10+ labels on a single slide,
all delivered in an easy-to-read report.

Read More



READY TO ACCELERATE YOUR RESEARCH?

Request a Quote

We will get back to you within an hour if request is submitted during normal
business hours


VISIKOL CONTRACT RESEARCH SERVICES



Visikol is a contract research services company that specializes in advanced
cell culture assays and advanced tissue imaging. Since its inception in 2016,
Visikol has developed a portfolio of tissue imaging and cell culture tools that
have been used by all of the top 20 pharmaceutical companies and over 1,000
research labs.




ADVANCED DRUG DISCOVERY



Visikol is focused on accelerating the drug discovery and development process by
providing pharmaceutical and biotech companies with advanced imaging and cell
culture tools. These tools ensure that drugs fail faster during the discovery
process and that researchers can answer more complex research questions to
inform their programs.




UNIQUE SERVICES



As a leader in advanced cell culture and imaging services, Visikol works closely
with its clients during their R&D process and sees itself as an extension of its
client’s R&D teams. Visikol has a suite of standard assays and services but also
routinely works with clients on custom development projects.





> “I am very impressed with the thoroughness of the analysis. I hope to steer
> more data your way soon. Again, thank you for undertaking this at a small
> cost. It is much appreciated.”

Marie M., Palatin Technologies

> “Thanks for getting this back so quickly, and for the thoroughness of the
> design and report. We look forward to working with you again!”

George M.

> “A pleasure to work with. Concise and detailed report for our 3D cell assay.
> We’ll have more projects your way soon!”

William Holden

> “Extremely impressive work, thanks for getting this back to us so quickly. I
> really appreciate the detailed analysis.”

Ray C.





FEATURED POSTS

 * 

Carol Tomaszewski2022-10-04T08:46:10-05:00

CREATING IMAGEJ MACROS WITH USER INPUTS

Carol Tomaszewski2022-10-04T08:46:10-05:00October 4th, 2022|

ImageJ is a wonderful, free program that has become somewhat of a standard for
image processing and quantification.  The applications of this program are only
limited by one’s imagination and familiarity of the internal [...]

 * 

Carol Tomaszewski2022-09-29T09:03:05-05:00

AN ACCOUNT MANAGERS GUIDE TO QUALITY CUSTOMER SERVICE IN BIOTECH

Carol Tomaszewski2022-09-29T09:03:05-05:00September 29th, 2022|

A service business exists solely for the purpose to help solve a problem for a
customer. This service can be to repair a car, fix plumbing, or invest savings.
In the biotechnology and pharmaceutical [...]

 * 

Carol Tomaszewski2022-09-27T12:15:23-05:00

RESEARCHERS USE HUREL MICRO LIVERS TO STUDY ULOTARONT

Carol Tomaszewski2022-09-27T12:15:23-05:00September 27th, 2022|

Ulotaront (SEP-363856) is a trace amine-associated receptor 1 (TAAR1) agonist
with 5-hydroxytryptamine type 1A (5-HT1A) and is in phase three of
clinical development for the treatment of schizophrenia [i]. Ulotaront has
demonstrated broad efficacy in [...]

 * 

Carol Tomaszewski2022-09-23T06:50:27-05:00

IMPLICATIONS OF USING A MICRO LIVER ASSAY IN RESEARCH

Carol Tomaszewski2022-09-23T06:50:27-05:00September 23rd, 2022|

HUREL cells are micro liver coculture of liver cells consisting of 30,000 liver
cells in each well of a 96-well plate. Using HUREL cells in in vitro experiments
is advantageous because they can mimic the [...]

 * 

Carol Tomaszewski2022-09-21T07:45:58-05:00

EMERGING TRENDS IN THERAPEUTICS BASED ON EPIGENETICS

Carol Tomaszewski2022-09-21T07:45:58-05:00September 21st, 2022|

Epigenetic mechanisms regulate gene transcription and genomic stability and
maintain normal cell growth, development, and differentiation. At the molecular
level, epigenetics involves a complex and dynamically reversible set of
structural modifications within the nucleic [...]

 * 

Carol Tomaszewski2022-09-20T10:40:53-05:00

CELL VIABILITY AND CYTOTOXICITY ASSESSMENT

Carol Tomaszewski2022-09-20T10:40:53-05:00September 20th, 2022|

When Pharmaceutical companies are developing new therapeutics, it is essential
to test the viability and cytotoxicity of those compounds on cells before
allowing them to be treated in a clinical setting. A major factor [...]

Previous Posts >>
SUBSCRIBE TO NEWSLETTER






OUR CLIENTS INCLUDE



Close product quick view×




Address:
Visikol, Inc.
53 Frontage Road,
Suite 120, Shelbourne Building,
Hampton, NJ 08827

Contact Information:
info@visikol.com
1-800-615-8474



CONNECT WITH US




Policies:
Supplier Code of Conduct
Internal Code of Conduct
Whistleblower/speak up channel



Visikol is a part of BICO. Our products reduce the organ shortage and speed up
drug development by providing accessible life science solutions that combine
biology and technology, fundamentally shifting the global healthcare industry.

Read more at BICO.com




© 2018-2022 Visikol, Inc. All rights reserved. Visikol® is a registered
trademark of Visikol, Inc. Visikol Products are patented. See
visikol.com/patents.| Privacy Policy | Sitemap

[contact-form-7 id=”6190″ title=”Request Quote Form”]

×
This website uses cookies to enhance the user experience. Ok